Elevated Lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
- 15 November 1996
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 127 (1), 27-34
- https://doi.org/10.1016/s0021-9150(96)05929-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Elevated Serum Lipoprotein(a) Is a Risk Factor for Clinical Recurrence After Coronary Balloon AngioplastyCirculation, 1995
- Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.Circulation, 1994
- Lipoprotein (a): A Risk Factor for Peripheral Vascular DiseaseAnnals of Vascular Surgery, 1993
- The relationship between serum lipoprotein (a) and Restenosis after initial elective percutaneous transluminal coronary angioplasty.Japanese Circulation Journal, 1993
- Lipoprotein [Lp(a)] and peripheral vascular diseaseJournal of Internal Medicine, 1992
- Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Lipoprotein(a) as a strong indicator for cerebrovascular disease.Stroke, 1986